Immunotherapy is a cancer treatment that enhances the body's natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.
This report contains market size and forecasts of Immunotherapeutic Drugs in Global, including the following market information:
Global Immunotherapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immunotherapeutic Drugs market was valued at 182290 million in 2021 and is projected to reach US$ 373820 million by 2028, at a CAGR of 10.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunotherapeutic Drugs include Roche, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie, ELI Lilly, Amgen and AstraZeneca and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunotherapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunotherapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immunotherapeutic Drugs Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
Global Immunotherapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immunotherapeutic Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Immunotherapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immunotherapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunotherapeutic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immunotherapeutic Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb